Inactive Instrument

Highlights Taro Pharmaceutical Industries Ltd. Other OTC

Equities

IL0010827181

End-of-day quote Other OTC Other stock markets
- ^USD	-

06-25	Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	CI
06-24	Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	06-23	CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	05-23	MT
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise	05-20	MT
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M	05-20	MT
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024	05-20	CI
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-20	CI
Taro Pharmaceutical Industries Fiscal Q3 Net Income, Net Sales Rise; Shares Climb After Hours	01-25	MT
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-25	CI
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln	01-17	RE
Taro Pharmaceutical to go Private in Merger Deal With Sun Pharmaceutical	01-17	MT
Sun Pharmaceutical to Take Taro Private at $43/Share	01-17	DJ
Taro Pharmaceutical Committee Agrees in Principle With Sun Pharmaceutical's Revised Acquisition Offer	12-12	MT
Sun Pharma Raises Offer to Buy Taro Pharmaceutical Industries' US Arm	12-12	CI
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	26/10/23	CI
Sun Pharmaceutical Industries Looking to Fully Acquire Its Israel-Based Unit Taro Pharmaceutical Industries	27/08/23	CI
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Posts Q1 Revenue $158.9M, vs. Street Est of $149M	27/07/23	MT
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023	27/07/23	CI
Taro Pharmaceutical's Shareholder Krensavage Says It 'Opposes' Sun Pharmaceutical Industries Takeover Offer	19/07/23	MT
Sun Pharmaceutical Industries Limited completed the acquisition of remaining unknown majority stake in Taro Pharmaceutical Industries Ltd..	29/06/23	CI
Taro Pharmaceutical Receives Takeover Offer From Sun Pharmaceutical for $38 Per Share in Cash	30/05/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Taro Pharmaceutical Industries Ltd. Other OTC

Equities

IL0010827181

Highlights

Filters